ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years
Olivera Grbovic-Huezo
Matched on ORCID iD 0000-0002-8011-7801; OpenAlex author ID A5009767609. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 45
2017: 1 paper · 2018: none · 2019: none · 2020: 3 papers · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper
Papers 6
- A Classical Epithelial State Drives Acute Resistance to KRAS Inhibition in Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-24-0740↗
- Systematic Comparison of Pancreatic Ductal Adenocarcinoma Models Identifies a Conserved Highly Plastic Basal Cell State. First author DOI 10.1158/0008-5472.can-22-1742↗
- Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer. Co-author DOI 10.1016/j.ccell.2020.05.010↗
- Unbiased in vivo preclinical evaluation of anticancer drugs identifies effective therapy for the treatment of pancreatic adenocarcinoma. Co-author DOI 10.1073/pnas.1920240117↗
- Tumor microtubes connect pancreatic cancer cells in an Arp2/3 complex-dependent manner. Co-author DOI 10.1091/mbc.e19-11-0605↗
- Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer. Co-author DOI 10.1038/nature24462↗
Closest collaborators
The 25 strongest of 45 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tuomas Tammela · 3 shared papers, 2020–2024 · strength 0.39
- Paper A Classical Epithelial State Drives Acute Resistance to KRAS Inhibition in Pancreatic Cancer. DOI 10.1158/2159-8290.cd-24-0740↗
- Paper Systematic Comparison of Pancreatic Ductal Adenocarcinoma Models Identifies a Conserved Highly Plastic Basal Cell State. DOI 10.1158/0008-5472.can-22-1742↗
- Paper Unbiased in vivo preclinical evaluation of anticancer drugs identifies effective therapy for the treatment of pancreati… DOI 10.1073/pnas.1920240117↗
- Steven D Leach · 4 shared papers, 2017–2020 · strength 0.31
- Paper Tumor microtubes connect pancreatic cancer cells in an Arp2/3 complex-dependent manner. DOI 10.1091/mbc.e19-11-0605↗
- Paper Unbiased in vivo preclinical evaluation of anticancer drugs identifies effective therapy for the treatment of pancreati… DOI 10.1073/pnas.1920240117↗
- Paper Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer. DOI 10.1016/j.ccell.2020.05.010↗
- Anupriya Singhal · 2 shared papers, 2022–2024 · strength 0.29
- Christine A. Iacobuzio–Donahue · 3 shared papers, 2017–2022 · strength 0.27
- Paper Systematic Comparison of Pancreatic Ductal Adenocarcinoma Models Identifies a Conserved Highly Plastic Basal Cell State. DOI 10.1158/0008-5472.can-22-1742↗
- Paper Unbiased in vivo preclinical evaluation of anticancer drugs identifies effective therapy for the treatment of pancreati… DOI 10.1073/pnas.1920240117↗
- Paper Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer. DOI 10.1038/nature24462↗
- Matilda Holm · 2 shared papers, 2020–2022 · strength 0.22
- Paper Systematic Comparison of Pancreatic Ductal Adenocarcinoma Models Identifies a Conserved Highly Plastic Basal Cell State. DOI 10.1158/0008-5472.can-22-1742↗
- Paper Unbiased in vivo preclinical evaluation of anticancer drugs identifies effective therapy for the treatment of pancreati… DOI 10.1073/pnas.1920240117↗
- Kenneth L Pitter · 2 shared papers, 2020–2022 · strength 0.22
- Paper Systematic Comparison of Pancreatic Ductal Adenocarcinoma Models Identifies a Conserved Highly Plastic Basal Cell State. DOI 10.1158/0008-5472.can-22-1742↗
- Paper Unbiased in vivo preclinical evaluation of anticancer drugs identifies effective therapy for the treatment of pancreati… DOI 10.1073/pnas.1920240117↗
- Olca Baştürk · 2 shared papers, 2017–2024 · strength 0.21
- Gökçe Aşkan · 3 shared papers, 2017–2020 · strength 0.21
- Paper Unbiased in vivo preclinical evaluation of anticancer drugs identifies effective therapy for the treatment of pancreati… DOI 10.1073/pnas.1920240117↗
- Paper Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer. DOI 10.1016/j.ccell.2020.05.010↗
- Paper Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer. DOI 10.1038/nature24462↗
- Iok In Christine Chio · 1 shared paper, 2024 · strength 0.17
- Rona D. Yaeger · 1 shared paper, 2024 · strength 0.17
- Dana Pe'er · 1 shared paper, 2022 · strength 0.13
- Simon Joost · 1 shared paper, 2022 · strength 0.13
- Henry N. Higgs · 1 shared paper, 2020 · strength 0.11
- Casey J. Latario · 1 shared paper, 2020 · strength 0.11
- Kerrington D. Smith · 1 shared paper, 2020 · strength 0.11
- Suhasini Joshi · 1 shared paper, 2020 · strength 0.10
- Caj H. Haglund · 1 shared paper, 2020 · strength 0.10
- Rohit Chandwani · 1 shared paper, 2020 · strength 0.10
- John P. Morris · 1 shared paper, 2020 · strength 0.07
- Chun‐Hao Pan · 1 shared paper, 2020 · strength 0.07
- Peter J. Bailey · 1 shared paper, 2020 · strength 0.07
- Scott W. Lowe · 1 shared paper, 2020 · strength 0.07
- Srivatsan Raghavan · 1 shared paper, 2020 · strength 0.07
- Andrew J. Aguirre · 1 shared paper, 2020 · strength 0.07
- Brian Matthew Wolpin · 1 shared paper, 2020 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.